1998
DOI: 10.1378/chest.114.3.827
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of Inhaled Nitric Oxide in Children With ARDS

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
19
0
2

Year Published

1999
1999
2017
2017

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 40 publications
(26 citation statements)
references
References 33 publications
5
19
0
2
Order By: Relevance
“…However, we did not find statistically significant changes in PaCO 2 and PVRI after INO administration. Okamoto et al (14) found that the magnitude of the decrease in PaCO 2 during INO was remarkable in patients with high baseline PaCO 2 values. Puybasset et al (19) showed that INO reversed the increase in pulmonary vascular resistance induced by acute hypercarbia.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, we did not find statistically significant changes in PaCO 2 and PVRI after INO administration. Okamoto et al (14) found that the magnitude of the decrease in PaCO 2 during INO was remarkable in patients with high baseline PaCO 2 values. Puybasset et al (19) showed that INO reversed the increase in pulmonary vascular resistance induced by acute hypercarbia.…”
Section: Discussionmentioning
confidence: 99%
“…Associations were described between level of the baseline pulmonary vascular resistance (6), level of the baseline PaO 2 /FiO 2 (14), and use of phenylephrine (15) and the effect of INO on arterial oxygenation. We could not determine which factors were associated with responsiveness to INO.…”
Section: Discussionmentioning
confidence: 99%
“…Abman et al, em 1994 34 , descreveram efeitos benéficos do gás sobre a oxigenação, HP e índice cardíaco em crianças com a síndrome. Posteriormente, estudos conduzidos em adultos 35,36 e em crianças 37,38 , enquanto confirmaram os efeitos benéficos imediatos, não foram capazes de demonstrar resposta prolongada da terapia com NOi. No entanto, Dobyns et al 39 observaram resposta prolongada ao NOi versus terapia com placebo em subgrupos de pacientes, aqueles com insuficiência respiratória mais grave (índice de oxigenação > 25) e nos pacientes imunodeprimidos.…”
Section: Hipertensão Pulmonar Persistente E Insuficiência Respiratóriunclassified
“…Abman et al, in 1994, 34 described beneficial effects on oxygenation, PH and cardiac index in children with the syndrome. Later, studies conducted on adults 35,36 and children, 37,38 while confirming the immediate beneficial effects, were not capable of demonstrating a prolonged response to iNO therapy. Dobyns et al, 39 however, observed a prolonged response to iNO as compared to therapy with a placebo in subgroups of patients; those with the most serious respiratory failure (oxygenation index > 25) and among immunodepressed patients.…”
Section: Acute Respiratory Distress Syndromementioning
confidence: 99%